Alpine Immune

ALPN NASDAQ
4.360
-0.140
-3.11%
交易中 13:34 06/18 EDT
开盘
4.500
昨收
4.500
最高
4.500
最低
4.270
成交量
4,379
成交均量(3M)
1.12万
52周最高
8.59
52周最低
3.660
换手率
0.02%
市值
8,097.02万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Alpine Immune ALPN股票价格,Alpine Immune股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Alpine Immune Sciences, Inc., formerly Nivalis Therapeutics, Inc., is focused on developing a protein-based immunotherapies using Variant immunoglobulin domain (vlgD) platform technology. The vlgD platform is designed to interact with multiple targets, including many present in the immune synapse. The vlgDs are developed using a process known as directed evolution. The vlgD platform exploits both known and unknown interactions at immune synapse through a process called direct evolution for patients living with cancer, autominnue/inflammatory conditions and chronic infectious disease. It optimizes native immune system proteins for use as therapeutics. The Company also developed Transmembrane Immunomodulatory Protien (TIP) technology, based on the vIgD platform, to enhance engineered cellular therapies. TIP program is created to help companies focused on engineered cellular therapies.
展开 >

最近浏览

名称
价格
涨跌幅